MX2009004985A - Secuencias para activar la expresión y control de las modificaciones de post-traducción de un polipéptido recombinante. - Google Patents

Secuencias para activar la expresión y control de las modificaciones de post-traducción de un polipéptido recombinante.

Info

Publication number
MX2009004985A
MX2009004985A MX2009004985A MX2009004985A MX2009004985A MX 2009004985 A MX2009004985 A MX 2009004985A MX 2009004985 A MX2009004985 A MX 2009004985A MX 2009004985 A MX2009004985 A MX 2009004985A MX 2009004985 A MX2009004985 A MX 2009004985A
Authority
MX
Mexico
Prior art keywords
polypeptide
post
recombinant
recombinant polypeptides
present
Prior art date
Application number
MX2009004985A
Other languages
English (en)
Inventor
Veronique Gomord
Claude Saint-Jore-Dupas
Aurelia Boulaflous
Marie-Christine Kieffer-Meyer
Loic Faye
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of MX2009004985A publication Critical patent/MX2009004985A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8221Transit peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

La presente invención proporciona nuevas herramientas para controlar las modificaciones de post-traducción de polipéptidos recombinantes. Estas herramientas son péptidos de señal particulares que permiten la activación de polipéptidos recombinantes durante su síntesis en una célula huésped para compartimientos sub-celulares específicos y un diseño específico de dichos polipéptidos recombinantes dentro de dichos compartimientos sub-celulares. Estos péptidos de señal son SEC ID No. 1 a SEC ID No. 31 y se describen aquí. La presente invención se refiere, por lo tanto, también a un procedimiento para producir un polipéptido recombinante, en particular a un polipéptido modificado de manera de post-traducción, que comprende los pasos de transfectar o transformar una célula con al menos un vector de ácido nucleico que codifica una proteína recombinante, la cual es el polipéptido que antes fe modificado de manera de post-traducción o una proteína recombinante diferente a dicho polipéptido. La proteína recombinante comprendiendo una señal de péptido de acuerdo con la presente invención; desarrollar la célula transfectada; y cosechar el polipéptido modificado de manera post-traducción; en donde, cuando dicha proteína recombinante es diferente al polipéptido, el método también comprende un paso de transfectar dicha célula con por lo menos un vector que codifica dicho polipéptido. La presente invención permite ventajosamente, por ejemplo, incrementar el rendimiento de producción de un polipéptido recombinante, para evitar la inmunogenicidad de polipéptidos recombinantes y para obtener polipéptidos recombinantes terapéuticamente activos que la copia exacta de su contraparte natural. Esta invención se refiere particularmente al campo de reorientación de plantas hechas farmacéuticos (PMP).
MX2009004985A 2006-11-08 2007-11-08 Secuencias para activar la expresión y control de las modificaciones de post-traducción de un polipéptido recombinante. MX2009004985A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85752406P 2006-11-08 2006-11-08
PCT/IB2007/004234 WO2008056265A2 (en) 2006-11-08 2007-11-08 A set of sequences for targeting expression and control of the post-translationnal modifications of a recombinant polypeptide

Publications (1)

Publication Number Publication Date
MX2009004985A true MX2009004985A (es) 2009-10-08

Family

ID=39364897

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004985A MX2009004985A (es) 2006-11-08 2007-11-08 Secuencias para activar la expresión y control de las modificaciones de post-traducción de un polipéptido recombinante.

Country Status (12)

Country Link
US (1) US20110195452A1 (es)
EP (1) EP2089526B1 (es)
JP (1) JP5568702B2 (es)
KR (1) KR20090079258A (es)
CN (1) CN101622354A (es)
AU (1) AU2007318926B2 (es)
BR (1) BRPI0716711A2 (es)
CA (1) CA2669455A1 (es)
IL (1) IL198659A (es)
MX (1) MX2009004985A (es)
RU (1) RU2481399C2 (es)
WO (1) WO2008056265A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013067322A1 (en) * 2011-11-03 2013-05-10 Stc Biologics, Inc. Method for determination of pharmacological properties of recombinant proteins
FR2991996B1 (fr) 2012-06-13 2016-07-08 Angany Genetics Methode de production d'allergenes recombinants de haute qualite par expression transitoire chez nicotiana benthamiana
FR3004462B1 (fr) 2013-04-15 2016-04-01 Angany Genetics Production commerciale de peptidases c1a par expression transitoire chez les plantes
US9796757B2 (en) * 2013-04-19 2017-10-24 The Board Of Trustees Of The University Of Illinois Compositions and method for treating thrombosis
FR3021328B1 (fr) 2014-05-23 2018-01-05 Angany Inc. Production commerciale de l'allergene amb a1 par expression transitoire chez les plantes
EA038931B9 (ru) * 2014-11-20 2022-02-18 Йиссум Рисерч Дивелопмент Компани Оф Зе Хебрю Юниверсити Оф Иерусалим Лтд. Композиции и способы получения полипептидов с модифицированным профилем гликозилирования в клетках растений
FR3054547B1 (fr) 2016-07-29 2020-06-05 Angany Inc. Particules pseudo-virales et leurs utilisations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2252960C2 (ru) * 1996-12-13 2005-05-27 Зингента Партисипейшнс Аг Ген, обусловливающий устойчивость растений к болезням, и его применение
WO2001029242A2 (en) * 1999-10-21 2001-04-26 Monsanto Company Post-translational modification of recombinant proteins produced in plants
FR2808286B1 (fr) * 2000-04-26 2004-12-17 Agronomique Inst Nat Rech Nouvelle glucosidase i de plante et son application a la production de proteines recombinantes a glycosylation modifiee
AU2003219418B2 (en) * 2002-03-19 2008-02-28 Stichting Dienst Landbouwkundig Onderzoek Optimizing glycan processing in plants

Also Published As

Publication number Publication date
EP2089526B1 (en) 2013-03-13
CA2669455A1 (en) 2008-05-15
AU2007318926A1 (en) 2008-05-15
US20110195452A1 (en) 2011-08-11
AU2007318926B2 (en) 2013-05-02
WO2008056265A2 (en) 2008-05-15
IL198659A0 (en) 2011-08-01
JP5568702B2 (ja) 2014-08-13
IL198659A (en) 2015-05-31
KR20090079258A (ko) 2009-07-21
RU2481399C2 (ru) 2013-05-10
EP2089526A2 (en) 2009-08-19
CN101622354A (zh) 2010-01-06
WO2008056265A3 (en) 2008-08-28
RU2009120298A (ru) 2010-12-20
BRPI0716711A2 (pt) 2013-10-01
JP2010508839A (ja) 2010-03-25

Similar Documents

Publication Publication Date Title
MX2009004985A (es) Secuencias para activar la expresión y control de las modificaciones de post-traducción de un polipéptido recombinante.
TW200732472A (en) Method for the recombinant expression of a polypeptide
WO2007011975A3 (en) Methods to express recombinant proteins from lentiviral vectors
RU2007124369A (ru) Производство белков
WO2006062398A3 (en) Methods for the production and secretion of modified peptides
US10000544B2 (en) Process for production of insulin and insulin analogues
DE602005020972D1 (en) Rhamnosepromotor-expressionssystem
Gotte et al. Structural and functional relationships of natural and artificial dimeric bovine ribonucleases: New scaffolds for potential antitumor drugs
MX2021003021A (es) Polipéptidos insecticidas mutantes de av3 y métodos para producción y uso de los mismos.
CA2261569A1 (en) Method for mass production of antimicrobial peptide
KR100484653B1 (ko) 원핵세포에서 활성형의 가용성 단백질을 제조하는 방법 및 이를 위한 폴리시스트론 벡터
EP2831262B1 (en) Secretion of functional insulin glargine directly into the culture medium through over expression of kex2p intracellularly
US9803207B2 (en) Expression vector for production of recombinant proteins in prokaryotic host cells
CN102659928A (zh) 一种人工合成的信号肽及其应用
CA2390049A1 (en) Control of post-transcriptional gene silencing in plants
IN2012DN03281A (es)
Yang et al. High level expression, purification and activation of human dipeptidyl peptidase I from mammalian cells
CN101921315B (zh) 一种人工合成的信号肽及其应用
CA2520537A1 (en) Process for producing plant storage organ with high production of recombinant protein and novel recombinant protein
MX2022003002A (es) Secuencia de extension n-terminal para la expresion de peptidos terapeuticos recombinantes.
Yan et al. Overexpression of a small medicinal peptide from ginseng in the yeast Pichia pastoris
KR101077783B1 (ko) 재조합 인간성장호르몬 단백질, 이의 발현 벡터, 및 이를 이용한 인간성장호르몬 단백질의 제조방법
TW200600581A (en) Nucleic acid construct and expression vector for enhancing the production of recombinant protein, and method for the massive production of recombinant protein
HK1089457A1 (en) Recombinant igf expression systems
US20220324937A1 (en) Methods for expressing human insulin derivative with a terminal lpxt thereof

Legal Events

Date Code Title Description
FG Grant or registration